BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15754121)

  • 1. Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer.
    Yonemori K; Katsumata N; Uno H; Matsumoto K; Kouno T; Tokunaga S; Yamanaka Y; Shimizu C; Ando M; Takeuchi M; Fujiwara Y
    Breast Cancer Res Treat; 2005 Feb; 89(3):237-41. PubMed ID: 15754121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and therapeutic efficacy of weekly 1-h low-dose paclitaxel infusion for relapsed breast cancer.
    Kim R; Osaki A; Toge T
    Oncol Rep; 2003; 10(1):145-50. PubMed ID: 12469161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weekly docetaxel/paclitaxel in pretreated metastatic breast cancer.
    Gennari A; Guarneri V; Landucci E; Orlandini C; Rondini M; Salvadori B; Ricci S; Conte PF
    Clin Breast Cancer; 2002 Dec; 3(5):346-52. PubMed ID: 12533265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weekly paclitaxel--an effective treatment for advanced breast cancer.
    Kellokumpu-Lehtinen P; Tuunanen T; Asola R; Elomaa L; Heikkinen M; Kokko R; Järvenpää R; Lehtinen I; Maiche A; Kaleva-Kerola J; Huusko M; Möykkynen K; Ala-Luhtala T
    Anticancer Res; 2013 Jun; 33(6):2623-7. PubMed ID: 23749918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of weekly albumin-bound paclitaxel for patients with metastatic breast cancer heavily pretreated with taxanes.
    Blum JL; Savin MA; Edelman G; Pippen JE; Robert NJ; Geister BV; Kirby RL; Clawson A; O'Shaughnessy JA
    Clin Breast Cancer; 2007 Dec; 7(11):850-6. PubMed ID: 18269774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial.
    Loibl S; Murmann C; Schwedler K; Warm M; Müller L; Heinrich G; Nekljudova V; von Minckwitz G
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):953-8. PubMed ID: 18716777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weekly paclitaxel versus weekly docetaxel in elderly or frail patients with metastatic breast carcinoma: a randomized phase-II study of the Belgian Society of Medical Oncology.
    Beuselinck B; Wildiers H; Wynendaele W; Dirix L; Kains JP; Paridaens R
    Crit Rev Oncol Hematol; 2010 Jul; 75(1):70-7. PubMed ID: 19651523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significantly longer progression-free survival with nab-paclitaxel compared with docetaxel as first-line therapy for metastatic breast cancer.
    Gradishar WJ; Krasnojon D; Cheporov S; Makhson AN; Manikhas GM; Clawson A; Bhar P
    J Clin Oncol; 2009 Aug; 27(22):3611-9. PubMed ID: 19470941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docetaxel in anthracycline-resistant metastatic breast cancer.
    Hui YF; Ignoffo RJ
    Cancer Pract; 1997; 5(2):124-7. PubMed ID: 9110651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel (Taxotere) for the treatment of anthracycline-resistant breast cancer.
    Ravdin PM
    Semin Oncol; 1997 Aug; 24(4 Suppl 10):S10-18-S10-21. PubMed ID: 9275002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Specenier P; Rasschaert M; Vroman P; Van den Brande J; Dyck J; Schrijvers D; Huizing MT; Vermorken JB
    Am J Clin Oncol; 2011 Oct; 34(5):472-7. PubMed ID: 20938321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective multicenter randomized phase III study of weekly versus standard docetaxel (D2) for first-line treatment of metastatic breast cancer.
    Stemmler HJ; Harbeck N; Gröll de Rivera I; Vehling Kaiser U; Rauthe G; Abenhardt W; Artmann A; Sommer H; Meerpohl HG; Kiechle M; Heinemann V
    Oncology; 2010; 79(3-4):197-203. PubMed ID: 21358207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of docetaxel in patients with paclitaxel-resistant advanced gastric cancer.
    Kondoh C; Takahari D; Shitara K; Mizota A; Nomura M; Yokota T; Ura T; Ito S; Kawai H; Sawaki A; Muro K
    Gan To Kagaku Ryoho; 2012 Oct; 39(10):1511-5. PubMed ID: 23064062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Weekly paclitaxel therapy for metastatic breast cancer].
    Kokufu I; Taniguchi H; Kimura F; Fukuda K; Yamamoto M; Yano T; Yamada K
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):221-6. PubMed ID: 11865627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer.
    Jones SE; Erban J; Overmoyer B; Budd GT; Hutchins L; Lower E; Laufman L; Sundaram S; Urba WJ; Pritchard KI; Mennel R; Richards D; Olsen S; Meyers ML; Ravdin PM
    J Clin Oncol; 2005 Aug; 23(24):5542-51. PubMed ID: 16110015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docetaxel plus cisplatin is effective for patients with metastatic breast cancer resistant to previous anthracycline treatment: a phase II clinical trial.
    Park SH; Cho EK; Bang SM; Shin DB; Lee JH; Lee YD
    BMC Cancer; 2005 Feb; 5():21. PubMed ID: 15723709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer: activity independence of prior docetaxel resistance.
    Moon YW; Sohn JH; Choi HJ; Chang H; Park BW; Kim SI; Park S; Koo JS; Kim YT; Roh JK; Chung HC; Kim JH
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):425-31. PubMed ID: 20012956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weekly paclitaxel in elderly patients (aged > or = 70 years) with advanced non-small-cell lung cancer: an alternative choice? Results of a phase II study.
    Rossi D; Dennetta D; Ugolini M; Alessandroni P; Catalano V; Fedeli SL; Giordani P; Casadei V; Baldelli AM; Graziano F; Catalano G
    Clin Lung Cancer; 2008 Sep; 9(5):280-4. PubMed ID: 18824450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case report of both CAF and docetaxel-resistant breast cancer responding to paclitaxel weekly therapy].
    Emoto T; Yoshikawa K; Fujikawa M; Fujii M; Yoshioka Y; Hamada E; Naka Y; Komaki T
    Gan To Kagaku Ryoho; 2002 May; 29(5):791-4. PubMed ID: 12040687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weekly paclitaxel as second-line chemotherapy for advanced or recurrent gastric cancer.
    Hironaka S; Zenda S; Boku N; Fukutomi A; Yoshino T; Onozawa Y
    Gastric Cancer; 2006; 9(1):14-8. PubMed ID: 16557431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.